Tiblan, Al-nashier A.
HRN: 25-77-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
08/27/2024
09/02/2024
PO
4.5mL
Q12
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes